Cochrane · systematic review · CD007505

Pharmacotherapy for anxiety and comorbid alcohol use disorders

Ipser, JC, Wilson, D, Akindipe, TO, et al. · Cochrane Database of Systematic Reviews · 2015 · Cochrane Library

Common Mental DisordersAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
7
current version
GRADE rated
6
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 1 · 14.3%Very low 6 · 85.7%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Paroxetine compared with placebo for anxiety and comorbid alcohol use disorders

Population: people with anxiety and comorbid alcohol use disorders
7 questions
OutcomeEffectEvidenceStatus / GRADE
Treatment responseCGI‐I
Paroxetine vs placebo
RR 2.23 [1.13, 4.41]2 studies · 57 participantsVery low
Downgraded: indirectness, publication bias
Symptom severity reductionLSAS
Paroxetine vs placebo
no estimate extracted2 studies · 44 participantsVery low
Downgraded: indirectness, publication bias
Treatment acceptability
Paroxetine vs placebo
RR 3.29 [0.14, 76.33]2 studies · 57 participantsVery low
Downgraded: imprecision, inconsistency, indirectness, publication bias
Proportion heavy drinking days
Paroxetine vs placebo
no estimate extracted0 studies · 0 participantsUngraded
Proportion of days abstinent
Paroxetine vs placebo
no estimate extracted2 studies · 54 participantsVery low
Downgraded: indirectness, publication bias
Drinks per drinking day
Paroxetine vs placebo
no estimate extracted2 studies · 54 participantsVery low
Downgraded: indirectness, publication bias
Depression symptom reduction
Paroxetine vs placebo
no estimate extracted1 study · 15 participantsVery low